Angela Bryan
Concepts (524)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual Behavior | 42 | 2023 | 490 | 8.150 |
Why?
| | Risk-Taking | 27 | 2023 | 333 | 6.370 |
Why?
| | Exercise | 37 | 2026 | 2198 | 5.910 |
Why?
| | Cannabis | 25 | 2026 | 518 | 5.750 |
Why?
| | Adolescent Behavior | 24 | 2021 | 517 | 5.090 |
Why?
| | Condoms | 28 | 2021 | 100 | 4.750 |
Why?
| | Alcohol Drinking | 29 | 2025 | 831 | 4.620 |
Why?
| | Cannabidiol | 13 | 2026 | 135 | 4.490 |
Why?
| | Marijuana Use | 13 | 2025 | 216 | 4.460 |
Why?
| | Marijuana Abuse | 17 | 2025 | 213 | 4.400 |
Why?
| | Dronabinol | 20 | 2026 | 249 | 4.330 |
Why?
| | Sexually Transmitted Diseases | 18 | 2021 | 168 | 4.210 |
Why?
| | Juvenile Delinquency | 16 | 2016 | 98 | 3.850 |
Why?
| | Intention | 15 | 2021 | 183 | 3.700 |
Why?
| | Affect | 14 | 2026 | 319 | 3.400 |
Why?
| | Marijuana Smoking | 15 | 2023 | 258 | 3.390 |
Why?
| | Motivation | 26 | 2026 | 607 | 2.810 |
Why?
| | Substance-Related Disorders | 16 | 2023 | 1082 | 2.650 |
Why?
| | Health Behavior | 18 | 2023 | 795 | 2.380 |
Why?
| | Risk Reduction Behavior | 8 | 2021 | 228 | 2.310 |
Why?
| | Attitude | 8 | 2021 | 257 | 2.130 |
Why?
| | HIV Infections | 22 | 2023 | 3061 | 2.050 |
Why?
| | Sexual and Gender Minorities | 4 | 2024 | 243 | 1.940 |
Why?
| | Adolescent | 95 | 2025 | 22282 | 1.910 |
Why?
| | Young Adult | 67 | 2026 | 13949 | 1.860 |
Why?
| | Female | 156 | 2026 | 77795 | 1.810 |
Why?
| | Male | 146 | 2026 | 71757 | 1.770 |
Why?
| | Exercise Therapy | 6 | 2025 | 469 | 1.670 |
Why?
| | Health Promotion | 11 | 2023 | 772 | 1.660 |
Why?
| | Unsafe Sex | 7 | 2018 | 61 | 1.650 |
Why?
| | Humans | 197 | 2026 | 144228 | 1.650 |
Why?
| | Brain | 17 | 2020 | 2909 | 1.590 |
Why?
| | Self Efficacy | 11 | 2018 | 412 | 1.560 |
Why?
| | Psychological Theory | 7 | 2021 | 92 | 1.550 |
Why?
| | Adult | 99 | 2026 | 40230 | 1.500 |
Why?
| | Health Knowledge, Attitudes, Practice | 11 | 2020 | 1407 | 1.480 |
Why?
| | Body Mass Index | 8 | 2024 | 2446 | 1.380 |
Why?
| | Cognition | 8 | 2023 | 1255 | 1.380 |
Why?
| | Prisoners | 6 | 2018 | 143 | 1.360 |
Why?
| | Cross-Over Studies | 2 | 2023 | 596 | 1.350 |
Why?
| | Homosexuality, Male | 4 | 2023 | 215 | 1.330 |
Why?
| | Pain | 3 | 2026 | 777 | 1.270 |
Why?
| | Hallucinogens | 9 | 2024 | 111 | 1.250 |
Why?
| | Anxiety | 5 | 2026 | 1104 | 1.240 |
Why?
| | Safe Sex | 7 | 2020 | 25 | 1.200 |
Why?
| | Diet | 4 | 2024 | 1270 | 1.140 |
Why?
| | Alcoholism | 14 | 2023 | 814 | 1.080 |
Why?
| | Fruit | 2 | 2019 | 151 | 1.070 |
Why?
| | Vegetables | 2 | 2019 | 170 | 1.050 |
Why?
| | Personal Satisfaction | 2 | 2024 | 223 | 1.030 |
Why?
| | Mindfulness | 4 | 2024 | 153 | 1.020 |
Why?
| | Magnetic Resonance Imaging | 22 | 2021 | 3842 | 1.020 |
Why?
| | Attitude to Health | 6 | 2018 | 436 | 0.950 |
Why?
| | Interpersonal Relations | 2 | 2024 | 404 | 0.940 |
Why?
| | Models, Statistical | 3 | 2026 | 680 | 0.940 |
Why?
| | Running | 3 | 2023 | 232 | 0.930 |
Why?
| | Surveys and Questionnaires | 31 | 2025 | 6031 | 0.910 |
Why?
| | Emotions | 4 | 2025 | 577 | 0.910 |
Why?
| | Middle Aged | 49 | 2026 | 35731 | 0.900 |
Why?
| | DNA Methylation | 6 | 2024 | 676 | 0.880 |
Why?
| | Puberty | 2 | 2018 | 154 | 0.880 |
Why?
| | Behavioral Medicine | 2 | 2023 | 43 | 0.880 |
Why?
| | Saliva | 4 | 2025 | 249 | 0.870 |
Why?
| | Longitudinal Studies | 16 | 2026 | 2955 | 0.860 |
Why?
| | Cannabinoids | 6 | 2026 | 180 | 0.860 |
Why?
| | Alcohol-Related Disorders | 6 | 2021 | 121 | 0.860 |
Why?
| | Feeding Behavior | 4 | 2019 | 684 | 0.850 |
Why?
| | Yoga | 1 | 2024 | 30 | 0.850 |
Why?
| | Decision Making | 5 | 2018 | 967 | 0.820 |
Why?
| | Overweight | 3 | 2021 | 608 | 0.820 |
Why?
| | Brain Mapping | 6 | 2018 | 536 | 0.820 |
Why?
| | Physical Fitness | 4 | 2020 | 208 | 0.810 |
Why?
| | Anti-Anxiety Agents | 1 | 2024 | 44 | 0.810 |
Why?
| | Sleep | 3 | 2026 | 905 | 0.800 |
Why?
| | Flowers | 6 | 2026 | 70 | 0.800 |
Why?
| | Health Education | 7 | 2009 | 358 | 0.800 |
Why?
| | Posture | 1 | 2024 | 195 | 0.790 |
Why?
| | Pain Management | 2 | 2026 | 399 | 0.760 |
Why?
| | Underage Drinking | 3 | 2021 | 23 | 0.750 |
Why?
| | Cues | 5 | 2019 | 325 | 0.740 |
Why?
| | Reward | 5 | 2018 | 244 | 0.720 |
Why?
| | Sexual Health | 1 | 2023 | 67 | 0.720 |
Why?
| | Coitus | 2 | 2020 | 23 | 0.720 |
Why?
| | Depression | 3 | 2025 | 1525 | 0.710 |
Why?
| | Smoking Cessation | 4 | 2017 | 436 | 0.700 |
Why?
| | Executive Function | 5 | 2020 | 456 | 0.690 |
Why?
| | Students | 11 | 2021 | 670 | 0.670 |
Why?
| | Medical Marijuana | 2 | 2020 | 123 | 0.670 |
Why?
| | Behavior Therapy | 4 | 2023 | 287 | 0.670 |
Why?
| | Varenicline | 2 | 2017 | 28 | 0.650 |
Why?
| | High-Intensity Interval Training | 1 | 2020 | 41 | 0.640 |
Why?
| | Sexual Partners | 3 | 2024 | 191 | 0.630 |
Why?
| | Attentional Bias | 1 | 2019 | 10 | 0.620 |
Why?
| | Attention | 3 | 2020 | 458 | 0.610 |
Why?
| | Parietal Lobe | 2 | 2019 | 60 | 0.600 |
Why?
| | Prisons | 2 | 2013 | 84 | 0.600 |
Why?
| | Sex Offenses | 2 | 2020 | 197 | 0.600 |
Why?
| | Irritable Bowel Syndrome | 1 | 2019 | 29 | 0.590 |
Why?
| | Models, Psychological | 9 | 2018 | 299 | 0.580 |
Why?
| | Delay Discounting | 2 | 2018 | 29 | 0.570 |
Why?
| | Motivational Interviewing | 4 | 2023 | 117 | 0.570 |
Why?
| | Motor Activity | 2 | 2013 | 722 | 0.560 |
Why?
| | Sex Education | 2 | 2016 | 34 | 0.560 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 128 | 0.550 |
Why?
| | Reaction Time | 2 | 2019 | 441 | 0.540 |
Why?
| | Limbic System | 1 | 2018 | 55 | 0.540 |
Why?
| | Obesity | 5 | 2023 | 3087 | 0.540 |
Why?
| | Body Weight Maintenance | 1 | 2017 | 17 | 0.530 |
Why?
| | Colorado | 14 | 2026 | 4591 | 0.530 |
Why?
| | Adolescent Development | 1 | 2018 | 76 | 0.530 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 562 | 0.520 |
Why?
| | Nerve Net | 2 | 2018 | 277 | 0.520 |
Why?
| | Mental Health | 2 | 2026 | 778 | 0.520 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 185 | 0.510 |
Why?
| | Smoking | 7 | 2017 | 1557 | 0.510 |
Why?
| | Tobacco Use Disorder | 2 | 2017 | 223 | 0.510 |
Why?
| | Homosexuality, Female | 2 | 2015 | 39 | 0.510 |
Why?
| | Aggression | 3 | 2015 | 179 | 0.500 |
Why?
| | Cerebral Cortex | 2 | 2018 | 467 | 0.500 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 828 | 0.500 |
Why?
| | Inflammation | 3 | 2025 | 2900 | 0.500 |
Why?
| | Genotype | 8 | 2014 | 1839 | 0.490 |
Why?
| | Insulin Resistance | 1 | 2025 | 1255 | 0.490 |
Why?
| | Crime Victims | 2 | 2018 | 130 | 0.490 |
Why?
| | Corpus Striatum | 1 | 2018 | 179 | 0.480 |
Why?
| | Follow-Up Studies | 13 | 2018 | 5327 | 0.480 |
Why?
| | Feedback, Psychological | 1 | 2016 | 23 | 0.480 |
Why?
| | Cognitive Neuroscience | 1 | 2016 | 9 | 0.470 |
Why?
| | Public Policy | 2 | 2015 | 77 | 0.470 |
Why?
| | Video Games | 1 | 2016 | 30 | 0.470 |
Why?
| | Research Design | 5 | 2019 | 1122 | 0.470 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 424 | 0.460 |
Why?
| | Psychotherapy | 1 | 2017 | 186 | 0.460 |
Why?
| | Feeding and Eating Disorders | 2 | 2014 | 162 | 0.450 |
Why?
| | Temporal Lobe | 1 | 2015 | 105 | 0.440 |
Why?
| | Criminals | 2 | 2014 | 34 | 0.440 |
Why?
| | Psychometrics | 7 | 2025 | 730 | 0.440 |
Why?
| | Risk Factors | 14 | 2017 | 10641 | 0.430 |
Why?
| | United States | 16 | 2026 | 15641 | 0.430 |
Why?
| | Coercion | 1 | 2014 | 9 | 0.430 |
Why?
| | Shame | 1 | 2014 | 12 | 0.430 |
Why?
| | Psychotherapy, Group | 3 | 2009 | 74 | 0.430 |
Why?
| | Research Subjects | 1 | 2014 | 43 | 0.430 |
Why?
| | Love | 2 | 2011 | 13 | 0.430 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2014 | 148 | 0.420 |
Why?
| | Gymnastics | 1 | 2014 | 20 | 0.420 |
Why?
| | Criminal Law | 1 | 2014 | 31 | 0.420 |
Why?
| | Mental Disorders | 2 | 2019 | 1129 | 0.420 |
Why?
| | Body Image | 2 | 2014 | 98 | 0.420 |
Why?
| | Patient Dropouts | 1 | 2014 | 65 | 0.420 |
Why?
| | Trust | 1 | 2015 | 150 | 0.400 |
Why?
| | Oxygen Consumption | 3 | 2023 | 725 | 0.400 |
Why?
| | Self Report | 7 | 2021 | 867 | 0.400 |
Why?
| | Aged | 15 | 2026 | 25675 | 0.390 |
Why?
| | Physical Exertion | 4 | 2023 | 211 | 0.390 |
Why?
| | Program Evaluation | 4 | 2013 | 953 | 0.390 |
Why?
| | Bacteria | 1 | 2020 | 892 | 0.390 |
Why?
| | Mobile Applications | 1 | 2016 | 190 | 0.390 |
Why?
| | Biomedical Research | 1 | 2019 | 714 | 0.380 |
Why?
| | Regression Analysis | 6 | 2016 | 1003 | 0.380 |
Why?
| | Patient Compliance | 2 | 2014 | 614 | 0.380 |
Why?
| | Task Performance and Analysis | 2 | 2015 | 199 | 0.370 |
Why?
| | Heterosexuality | 3 | 2011 | 43 | 0.370 |
Why?
| | Social Norms | 3 | 2018 | 29 | 0.370 |
Why?
| | Breast Neoplasms | 2 | 2017 | 2502 | 0.370 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 753 | 0.350 |
Why?
| | Cell Phone | 1 | 2012 | 80 | 0.350 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2012 | 46 | 0.350 |
Why?
| | Receptors, Dopamine D2 | 4 | 2018 | 93 | 0.350 |
Why?
| | Heart Rate | 4 | 2026 | 843 | 0.340 |
Why?
| | Cross-Sectional Studies | 10 | 2021 | 5776 | 0.340 |
Why?
| | Social Desirability | 1 | 2011 | 13 | 0.340 |
Why?
| | Courtship | 1 | 2011 | 11 | 0.340 |
Why?
| | Weight Loss | 2 | 2021 | 837 | 0.330 |
Why?
| | Social Dominance | 1 | 2011 | 18 | 0.330 |
Why?
| | Peer Group | 4 | 2020 | 254 | 0.330 |
Why?
| | Self-Control | 2 | 2024 | 56 | 0.330 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2024 | 1692 | 0.330 |
Why?
| | Health Risk Behaviors | 2 | 2020 | 15 | 0.330 |
Why?
| | Gray Matter | 3 | 2021 | 89 | 0.320 |
Why?
| | Factor Analysis, Statistical | 5 | 2025 | 291 | 0.320 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1330 | 0.320 |
Why?
| | Reproducibility of Results | 11 | 2025 | 3402 | 0.320 |
Why?
| | Research | 3 | 2015 | 427 | 0.310 |
Why?
| | Universities | 5 | 2020 | 455 | 0.310 |
Why?
| | Genomics | 2 | 2012 | 836 | 0.310 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 707 | 0.290 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2014 | 2178 | 0.290 |
Why?
| | Phenotype | 6 | 2022 | 3185 | 0.280 |
Why?
| | White Matter | 2 | 2021 | 151 | 0.280 |
Why?
| | Psychotic Disorders | 2 | 2022 | 170 | 0.270 |
Why?
| | Impulsive Behavior | 5 | 2017 | 144 | 0.270 |
Why?
| | Urban Population | 2 | 2009 | 485 | 0.260 |
Why?
| | Antipsychotic Agents | 2 | 2022 | 185 | 0.260 |
Why?
| | Aging | 3 | 2026 | 1972 | 0.260 |
Why?
| | Testosterone | 1 | 2011 | 427 | 0.260 |
Why?
| | Software | 1 | 2012 | 692 | 0.260 |
Why?
| | Individuality | 2 | 2009 | 152 | 0.250 |
Why?
| | Fatigue | 3 | 2016 | 358 | 0.250 |
Why?
| | Life Style | 3 | 2017 | 485 | 0.240 |
Why?
| | Prospective Studies | 6 | 2018 | 7911 | 0.240 |
Why?
| | Sex Factors | 8 | 2025 | 2081 | 0.240 |
Why?
| | Age Factors | 7 | 2026 | 3295 | 0.240 |
Why?
| | Treatment Outcome | 12 | 2022 | 11501 | 0.230 |
Why?
| | Pilot Projects | 4 | 2022 | 1858 | 0.230 |
Why?
| | Endocannabinoids | 1 | 2026 | 57 | 0.220 |
Why?
| | Eicosanoids | 1 | 2025 | 58 | 0.220 |
Why?
| | Gender Identity | 2 | 2023 | 124 | 0.220 |
Why?
| | Cardiorespiratory Fitness | 1 | 2025 | 70 | 0.210 |
Why?
| | Psilocybin | 1 | 2024 | 5 | 0.210 |
Why?
| | Cluster Analysis | 2 | 2018 | 530 | 0.210 |
Why?
| | Loneliness | 1 | 2025 | 59 | 0.210 |
Why?
| | Meditation | 1 | 2024 | 35 | 0.210 |
Why?
| | Autonomic Nervous System | 1 | 2024 | 79 | 0.210 |
Why?
| | Pleasure | 1 | 2023 | 17 | 0.210 |
Why?
| | Minority Health | 1 | 2023 | 18 | 0.200 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2024 | 116 | 0.200 |
Why?
| | Progesterone | 1 | 2025 | 256 | 0.200 |
Why?
| | Logistic Models | 2 | 2007 | 2096 | 0.200 |
Why?
| | Hydrocortisone | 1 | 2025 | 306 | 0.200 |
Why?
| | Double-Blind Method | 3 | 2024 | 2023 | 0.190 |
Why?
| | Body Weight | 2 | 2017 | 993 | 0.190 |
Why?
| | Cooking | 1 | 2023 | 66 | 0.190 |
Why?
| | Automobile Driving | 2 | 2007 | 154 | 0.190 |
Why?
| | Ethanol | 3 | 2021 | 626 | 0.190 |
Why?
| | Exercise Test | 2 | 2017 | 621 | 0.180 |
Why?
| | Weight Lifting | 1 | 2002 | 32 | 0.180 |
Why?
| | Exploratory Behavior | 4 | 2015 | 86 | 0.180 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2021 | 9 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 483 | 0.170 |
Why?
| | Prevalence | 4 | 2024 | 2820 | 0.170 |
Why?
| | Analysis of Variance | 5 | 2011 | 1309 | 0.170 |
Why?
| | Tobacco Use | 2 | 2019 | 64 | 0.170 |
Why?
| | Receptors, Dopamine D4 | 4 | 2009 | 26 | 0.170 |
Why?
| | Peer Influence | 1 | 2020 | 14 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 312 | 0.160 |
Why?
| | Sexuality | 2 | 1997 | 30 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2012 | 1509 | 0.160 |
Why?
| | Sensation Disorders | 1 | 2020 | 41 | 0.160 |
Why?
| | Occupations | 1 | 2000 | 50 | 0.160 |
Why?
| | Appetite | 1 | 2020 | 71 | 0.160 |
Why?
| | Ecological Momentary Assessment | 1 | 2020 | 44 | 0.160 |
Why?
| | Neuropsychological Tests | 4 | 2018 | 1125 | 0.160 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 94 | 0.150 |
Why?
| | Occupational Diseases | 1 | 2001 | 161 | 0.150 |
Why?
| | Behavior, Addictive | 2 | 2019 | 89 | 0.150 |
Why?
| | CpG Islands | 2 | 2017 | 167 | 0.150 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8154 | 0.150 |
Why?
| | Heroin Dependence | 1 | 2000 | 33 | 0.150 |
Why?
| | Socioeconomic Factors | 3 | 2015 | 1327 | 0.150 |
Why?
| | Drug and Narcotic Control | 1 | 2019 | 24 | 0.150 |
Why?
| | Diet Surveys | 1 | 2019 | 92 | 0.150 |
Why?
| | Knowledge | 1 | 2019 | 57 | 0.150 |
Why?
| | Migraine Disorders | 1 | 2020 | 109 | 0.150 |
Why?
| | Self Concept | 2 | 2014 | 253 | 0.150 |
Why?
| | Statistics as Topic | 2 | 2012 | 279 | 0.140 |
Why?
| | Methadone | 1 | 2000 | 108 | 0.140 |
Why?
| | Plant Extracts | 1 | 2020 | 194 | 0.140 |
Why?
| | DNA, Bacterial | 1 | 2020 | 341 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2024 | 549 | 0.140 |
Why?
| | Hostility | 2 | 2015 | 16 | 0.140 |
Why?
| | Social Behavior | 2 | 2018 | 291 | 0.140 |
Why?
| | Qualitative Research | 1 | 2026 | 1640 | 0.140 |
Why?
| | Self Disclosure | 2 | 2009 | 65 | 0.140 |
Why?
| | Taste | 2 | 2018 | 238 | 0.140 |
Why?
| | Cancer Survivors | 1 | 2023 | 314 | 0.140 |
Why?
| | Anger | 2 | 2015 | 60 | 0.140 |
Why?
| | Hyperkinesis | 1 | 2017 | 16 | 0.130 |
Why?
| | Chronic Pain | 1 | 2022 | 283 | 0.130 |
Why?
| | Polymorphism, Genetic | 3 | 2008 | 618 | 0.130 |
Why?
| | Internal-External Control | 1 | 1997 | 74 | 0.130 |
Why?
| | Information Dissemination | 1 | 2019 | 217 | 0.130 |
Why?
| | Drinking | 1 | 2017 | 42 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 104 | 0.130 |
Why?
| | Cytokines | 1 | 2025 | 2098 | 0.130 |
Why?
| | Cannabinoid Receptor Agonists | 3 | 2021 | 44 | 0.130 |
Why?
| | Alcoholic Beverages | 1 | 2017 | 30 | 0.130 |
Why?
| | Single Person | 1 | 1996 | 7 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2025 | 1150 | 0.120 |
Why?
| | Transcriptome | 1 | 2023 | 1049 | 0.120 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 526 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2019 | 327 | 0.120 |
Why?
| | Southwestern United States | 2 | 2017 | 95 | 0.120 |
Why?
| | Nicotinic Agonists | 1 | 2017 | 136 | 0.120 |
Why?
| | Nutrition Surveys | 1 | 2017 | 279 | 0.120 |
Why?
| | Nucleus Accumbens | 2 | 2015 | 132 | 0.120 |
Why?
| | Social Discrimination | 1 | 2015 | 9 | 0.120 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 467 | 0.120 |
Why?
| | Conduct Disorder | 1 | 2017 | 158 | 0.110 |
Why?
| | Social Justice | 1 | 2016 | 86 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2413 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 288 | 0.110 |
Why?
| | Incidence | 2 | 2020 | 2852 | 0.110 |
Why?
| | Mental Recall | 1 | 2016 | 221 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 454 | 0.110 |
Why?
| | Athletic Performance | 1 | 2015 | 76 | 0.110 |
Why?
| | Goals | 1 | 2016 | 177 | 0.110 |
Why?
| | Protective Factors | 1 | 2014 | 102 | 0.100 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2013 | 28 | 0.100 |
Why?
| | Retinal Dehydrogenase | 1 | 2013 | 30 | 0.100 |
Why?
| | Anisotropy | 1 | 2013 | 78 | 0.100 |
Why?
| | Personality Inventory | 4 | 2011 | 134 | 0.100 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 686 | 0.100 |
Why?
| | Benzodiazepines | 1 | 2014 | 155 | 0.100 |
Why?
| | Diffusion Tensor Imaging | 1 | 2013 | 75 | 0.100 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 47 | 0.100 |
Why?
| | Models, Economic | 1 | 2013 | 61 | 0.100 |
Why?
| | Norepinephrine | 1 | 2013 | 196 | 0.100 |
Why?
| | India | 3 | 2007 | 217 | 0.100 |
Why?
| | Body Temperature | 1 | 2013 | 223 | 0.090 |
Why?
| | Auditory Perception | 1 | 2013 | 114 | 0.090 |
Why?
| | Body Weights and Measures | 1 | 2012 | 36 | 0.090 |
Why?
| | Artifacts | 1 | 2013 | 140 | 0.090 |
Why?
| | Connecticut | 3 | 2008 | 26 | 0.090 |
Why?
| | Lactic Acid | 1 | 2013 | 305 | 0.090 |
Why?
| | Comorbidity | 2 | 2012 | 1638 | 0.090 |
Why?
| | Residential Treatment | 1 | 2012 | 26 | 0.090 |
Why?
| | Microbiota | 1 | 2020 | 782 | 0.090 |
Why?
| | Speech | 1 | 2012 | 77 | 0.090 |
Why?
| | Biomarkers | 3 | 2025 | 4258 | 0.090 |
Why?
| | Interview, Psychological | 1 | 2012 | 94 | 0.090 |
Why?
| | Nursing Research | 1 | 2012 | 52 | 0.090 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2011 | 10 | 0.090 |
Why?
| | Secondary Prevention | 2 | 2023 | 238 | 0.090 |
Why?
| | Visual Perception | 1 | 2013 | 183 | 0.090 |
Why?
| | Sex Characteristics | 2 | 2021 | 786 | 0.090 |
Why?
| | Sampling Studies | 1 | 2011 | 100 | 0.090 |
Why?
| | Minnesota | 1 | 2012 | 169 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 838 | 0.090 |
Why?
| | Genetic Markers | 1 | 2012 | 338 | 0.080 |
Why?
| | Authoritarianism | 1 | 2011 | 12 | 0.080 |
Why?
| | Child | 5 | 2015 | 22493 | 0.080 |
Why?
| | Beauty | 1 | 2011 | 19 | 0.080 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2013 | 286 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 619 | 0.080 |
Why?
| | Odorants | 1 | 2011 | 119 | 0.080 |
Why?
| | Anorexia Nervosa | 1 | 2011 | 78 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2014 | 542 | 0.080 |
Why?
| | Interviews as Topic | 2 | 2007 | 890 | 0.080 |
Why?
| | Smell | 1 | 2011 | 132 | 0.080 |
Why?
| | Forecasting | 1 | 2011 | 390 | 0.080 |
Why?
| | Menstrual Cycle | 1 | 2011 | 140 | 0.080 |
Why?
| | Photic Stimulation | 2 | 2013 | 264 | 0.080 |
Why?
| | Genome, Human | 1 | 2012 | 429 | 0.080 |
Why?
| | Craving | 2 | 2023 | 39 | 0.070 |
Why?
| | Genetic Variation | 2 | 2012 | 990 | 0.070 |
Why?
| | Minisatellite Repeats | 3 | 2008 | 36 | 0.070 |
Why?
| | Pregnancy in Adolescence | 1 | 2009 | 85 | 0.070 |
Why?
| | Psychotherapy, Brief | 1 | 2009 | 42 | 0.070 |
Why?
| | Alcoholic Intoxication | 1 | 2009 | 74 | 0.070 |
Why?
| | Biological Evolution | 1 | 2012 | 489 | 0.070 |
Why?
| | Internet | 1 | 2013 | 699 | 0.070 |
Why?
| | Recurrence | 1 | 2012 | 1123 | 0.070 |
Why?
| | Social Conformity | 1 | 2007 | 11 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 1029 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2914 | 0.060 |
Why?
| | Computers | 1 | 2007 | 70 | 0.060 |
Why?
| | Exons | 1 | 2008 | 358 | 0.060 |
Why?
| | Motor Vehicles | 1 | 2007 | 30 | 0.060 |
Why?
| | Blood Pressure | 1 | 2013 | 1752 | 0.060 |
Why?
| | Homoserine | 1 | 2006 | 6 | 0.060 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 16 | 0.060 |
Why?
| | Judgment | 1 | 2007 | 67 | 0.060 |
Why?
| | Adoption | 1 | 2006 | 25 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2007 | 104 | 0.060 |
Why?
| | Lipoxygenase | 1 | 2025 | 15 | 0.060 |
Why?
| | South Africa | 1 | 2006 | 221 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2007 | 230 | 0.060 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2025 | 74 | 0.060 |
Why?
| | Functional Neuroimaging | 2 | 2017 | 60 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 371 | 0.060 |
Why?
| | Reflex, Startle | 1 | 2005 | 76 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 326 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2006 | 251 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 968 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2025 | 162 | 0.050 |
Why?
| | Patient Education as Topic | 2 | 2009 | 794 | 0.050 |
Why?
| | Risk | 1 | 2007 | 902 | 0.050 |
Why?
| | Social Perception | 1 | 2005 | 107 | 0.050 |
Why?
| | Environment | 1 | 2006 | 306 | 0.050 |
Why?
| | Food Preferences | 2 | 2017 | 126 | 0.050 |
Why?
| | Cold Temperature | 1 | 2025 | 203 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2006 | 350 | 0.050 |
Why?
| | Social Class | 1 | 2025 | 270 | 0.050 |
Why?
| | Minority Groups | 1 | 2025 | 282 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2009 | 703 | 0.050 |
Why?
| | Habits | 1 | 2023 | 52 | 0.050 |
Why?
| | Models, Theoretical | 2 | 2008 | 586 | 0.050 |
Why?
| | Contraception Behavior | 2 | 2018 | 107 | 0.050 |
Why?
| | New Mexico | 2 | 2014 | 103 | 0.050 |
Why?
| | Gene Frequency | 1 | 2004 | 483 | 0.050 |
Why?
| | Genetics, Population | 1 | 2004 | 213 | 0.050 |
Why?
| | Child Behavior | 1 | 2004 | 239 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 517 | 0.050 |
Why?
| | Time Factors | 2 | 2011 | 7081 | 0.050 |
Why?
| | Smokers | 1 | 2023 | 148 | 0.050 |
Why?
| | Risk Assessment | 1 | 2011 | 3560 | 0.040 |
Why?
| | Pregnancy | 3 | 2012 | 7180 | 0.040 |
Why?
| | Agoraphobia | 1 | 2001 | 8 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 877 | 0.040 |
Why?
| | Physicians, Women | 1 | 2002 | 87 | 0.040 |
Why?
| | Models, Genetic | 1 | 2004 | 535 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2023 | 288 | 0.040 |
Why?
| | Georgia | 1 | 2021 | 86 | 0.040 |
Why?
| | Harm Reduction | 1 | 2021 | 49 | 0.040 |
Why?
| | Psychomotor Disorders | 1 | 2020 | 14 | 0.040 |
Why?
| | Eating | 2 | 2014 | 389 | 0.040 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2001 | 58 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1844 | 0.040 |
Why?
| | Suicide, Attempted | 1 | 2024 | 380 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 788 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2032 | 0.040 |
Why?
| | Quality of Life | 1 | 2012 | 3146 | 0.040 |
Why?
| | Verbal Learning | 1 | 2020 | 72 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 791 | 0.040 |
Why?
| | School Health Services | 1 | 2002 | 229 | 0.040 |
Why?
| | Spouses | 1 | 2000 | 107 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2022 | 377 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 308 | 0.040 |
Why?
| | Substance Abuse, Intravenous | 1 | 2000 | 127 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 243 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2024 | 854 | 0.030 |
Why?
| | Placebo Effect | 1 | 2017 | 25 | 0.030 |
Why?
| | Achievement | 1 | 2018 | 58 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2022 | 568 | 0.030 |
Why?
| | Tobacco Smoking | 1 | 2017 | 25 | 0.030 |
Why?
| | Psychomotor Performance | 1 | 2020 | 329 | 0.030 |
Why?
| | Benzazepines | 1 | 2017 | 35 | 0.030 |
Why?
| | Personality Assessment | 1 | 1997 | 78 | 0.030 |
Why?
| | Social Adjustment | 1 | 2017 | 64 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 246 | 0.030 |
Why?
| | Beverages | 1 | 2017 | 69 | 0.030 |
Why?
| | Family | 1 | 2001 | 692 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 471 | 0.030 |
Why?
| | Self-Assessment | 1 | 1996 | 77 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2004 | 3618 | 0.030 |
Why?
| | Anticipation, Psychological | 1 | 2015 | 20 | 0.030 |
Why?
| | Smoking Prevention | 2 | 2007 | 170 | 0.030 |
Why?
| | Drive | 1 | 2014 | 2 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 1994 | 29 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1682 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 1994 | 14 | 0.030 |
Why?
| | Anesthesia, Intravenous | 1 | 1994 | 25 | 0.030 |
Why?
| | Bulimia | 1 | 2014 | 35 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 505 | 0.030 |
Why?
| | Event-Related Potentials, P300 | 1 | 2013 | 15 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 432 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 399 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2019 | 16805 | 0.030 |
Why?
| | Drug-Seeking Behavior | 1 | 2013 | 22 | 0.030 |
Why?
| | Thinness | 1 | 2014 | 99 | 0.030 |
Why?
| | Ambulatory Surgical Procedures | 1 | 1994 | 76 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1135 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1256 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2013 | 2097 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1328 | 0.020 |
Why?
| | Evoked Potentials | 1 | 2013 | 128 | 0.020 |
Why?
| | Quality Control | 1 | 2013 | 165 | 0.020 |
Why?
| | Motion | 1 | 2013 | 100 | 0.020 |
Why?
| | Wechsler Scales | 1 | 2012 | 59 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 332 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2014 | 270 | 0.020 |
Why?
| | Personality | 1 | 2013 | 132 | 0.020 |
Why?
| | Life Change Events | 1 | 2012 | 146 | 0.020 |
Why?
| | Image Enhancement | 1 | 2013 | 202 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 883 | 0.020 |
Why?
| | Contraceptives, Oral | 1 | 2011 | 37 | 0.020 |
Why?
| | Psychological Tests | 1 | 2011 | 130 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2012 | 181 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2930 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 711 | 0.020 |
Why?
| | Global Health | 1 | 2012 | 394 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2011 | 375 | 0.020 |
Why?
| | Temperance | 1 | 2009 | 20 | 0.020 |
Why?
| | Women's Health | 1 | 2011 | 311 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 550 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1986 | 0.020 |
Why?
| | Precision Medicine | 1 | 2012 | 457 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 517 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 128 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2011 | 435 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 1002 | 0.020 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 28 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2006 | 151 | 0.020 |
Why?
| | Homosexuality | 1 | 2006 | 17 | 0.010 |
Why?
| | Twins, Dizygotic | 1 | 2006 | 107 | 0.010 |
Why?
| | Cytosol | 1 | 2006 | 226 | 0.010 |
Why?
| | Parents | 1 | 2014 | 1415 | 0.010 |
Why?
| | Twins, Monozygotic | 1 | 2006 | 132 | 0.010 |
Why?
| | Social Values | 1 | 2005 | 39 | 0.010 |
Why?
| | Siblings | 1 | 2006 | 196 | 0.010 |
Why?
| | Stereotyping | 1 | 2005 | 46 | 0.010 |
Why?
| | Virulence Factors | 1 | 2006 | 172 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 331 | 0.010 |
Why?
| | Data Collection | 1 | 2007 | 635 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 992 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2006 | 266 | 0.010 |
Why?
| | Binding Sites | 1 | 2007 | 1313 | 0.010 |
Why?
| | Age Distribution | 1 | 2004 | 396 | 0.010 |
Why?
| | Sex Distribution | 1 | 2004 | 380 | 0.010 |
Why?
| | Ontario | 1 | 2002 | 94 | 0.010 |
Why?
| | Marital Status | 1 | 2002 | 47 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1193 | 0.010 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2002 | 80 | 0.010 |
Why?
| | Poverty Areas | 1 | 2002 | 41 | 0.010 |
Why?
| | DNA | 1 | 2008 | 1430 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2004 | 280 | 0.010 |
Why?
| | Models, Educational | 1 | 2002 | 89 | 0.010 |
Why?
| | Fibroblasts | 1 | 2006 | 1035 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 174 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2006 | 864 | 0.010 |
Why?
| | Gynecology | 1 | 2002 | 177 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2630 | 0.010 |
Why?
| | Apoptosis | 1 | 2006 | 2450 | 0.010 |
Why?
| | Animals | 2 | 2012 | 38231 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2001 | 598 | 0.010 |
Why?
| | Enflurane | 1 | 1994 | 4 | 0.010 |
Why?
| | Surgery, Oral | 1 | 1994 | 7 | 0.010 |
Why?
| | Halothane | 1 | 1994 | 7 | 0.010 |
Why?
| | Cohort Studies | 1 | 2004 | 5876 | 0.010 |
Why?
| | Isoflurane | 1 | 1994 | 41 | 0.010 |
Why?
| | Eye Movements | 1 | 1994 | 92 | 0.010 |
Why?
| | Propofol | 1 | 1994 | 89 | 0.010 |
Why?
| | Mice | 1 | 2006 | 18471 | 0.000 |
Why?
|
|
Bryan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|